Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The overall pipeline

<< Previous

Bullboard Posts

Next >>

Comment by Johnandrose22on Nov 10, 2024 6:50pm

234 Views

Post# 36305926

RE:RE:RE:RE:The overall pipeline

A remarkable CR and jaw dropping durability...with often just one instillation...One!....Data confirmed by an FDA central lab....C'mon...just confirm this and start saving the lives of our family, neighbors and those we will never know.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant